Integral Ad Science’s (IAS) Hold Rating Reiterated at Benchmark

Benchmark restated their hold rating on shares of Integral Ad Science (NASDAQ:IASFree Report) in a research report report published on Thursday,Benzinga reports.

Several other research firms have also issued reports on IAS. Raymond James increased their price target on shares of Integral Ad Science from $13.00 to $15.00 and gave the stock an “outperform” rating in a research report on Friday, August 2nd. Morgan Stanley increased their target price on Integral Ad Science from $12.00 to $13.00 and gave the stock an “equal weight” rating in a report on Tuesday, July 23rd. Barclays boosted their price target on Integral Ad Science from $12.00 to $13.00 and gave the company an “equal weight” rating in a research note on Monday, August 5th. Piper Sandler dropped their price objective on Integral Ad Science from $18.00 to $16.00 and set an “overweight” rating for the company in a research note on Wednesday. Finally, Truist Financial cut their price objective on Integral Ad Science from $18.00 to $16.00 and set a “buy” rating for the company in a report on Wednesday. Three equities research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $15.70.

Read Our Latest Research Report on IAS

Integral Ad Science Price Performance

Shares of IAS stock opened at $10.11 on Thursday. The company has a market capitalization of $1.64 billion, a P/E ratio of 50.55, a P/E/G ratio of 1.40 and a beta of 1.52. The company has a current ratio of 3.71, a quick ratio of 3.76 and a debt-to-equity ratio of 0.07. Integral Ad Science has a 12 month low of $7.98 and a 12 month high of $17.53. The stock has a 50 day moving average of $11.09 and a two-hundred day moving average of $10.47.

Integral Ad Science (NASDAQ:IASGet Free Report) last issued its earnings results on Tuesday, November 12th. The company reported $0.10 EPS for the quarter, topping the consensus estimate of $0.08 by $0.02. Integral Ad Science had a return on equity of 3.47% and a net margin of 6.39%. The firm had revenue of $133.50 million during the quarter, compared to analysts’ expectations of $138.06 million. During the same period last year, the business earned ($0.09) earnings per share. Integral Ad Science’s quarterly revenue was up 11.0% compared to the same quarter last year. As a group, equities analysts expect that Integral Ad Science will post 0.26 EPS for the current year.

Insider Activity at Integral Ad Science

In related news, CFO Tania Secor sold 5,240 shares of the firm’s stock in a transaction that occurred on Monday, October 7th. The shares were sold at an average price of $10.11, for a total value of $52,976.40. Following the completion of the sale, the chief financial officer now owns 248,223 shares of the company’s stock, valued at $2,509,534.53. This trade represents a 2.07 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CEO Lisa Utzschneider sold 10,481 shares of the business’s stock in a transaction that occurred on Monday, October 7th. The stock was sold at an average price of $10.11, for a total transaction of $105,962.91. Following the completion of the transaction, the chief executive officer now owns 239,709 shares of the company’s stock, valued at $2,423,457.99. This trade represents a 4.19 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 23,006 shares of company stock valued at $240,296 over the last ninety days. 2.00% of the stock is owned by insiders.

Hedge Funds Weigh In On Integral Ad Science

Several hedge funds have recently added to or reduced their stakes in the company. Point72 DIFC Ltd acquired a new position in Integral Ad Science during the 3rd quarter valued at about $41,000. nVerses Capital LLC bought a new stake in shares of Integral Ad Science during the third quarter worth approximately $45,000. Ameritas Investment Partners Inc. boosted its stake in Integral Ad Science by 40.1% in the first quarter. Ameritas Investment Partners Inc. now owns 6,724 shares of the company’s stock valued at $67,000 after acquiring an additional 1,924 shares during the last quarter. Quantbot Technologies LP acquired a new stake in Integral Ad Science during the 3rd quarter worth $106,000. Finally, XTX Topco Ltd bought a new stake in shares of Integral Ad Science during the 2nd quarter valued at $113,000. Institutional investors own 95.78% of the company’s stock.

Integral Ad Science Company Profile

(Get Free Report)

Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.

Read More

Analyst Recommendations for Integral Ad Science (NASDAQ:IAS)

Receive News & Ratings for Integral Ad Science Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integral Ad Science and related companies with MarketBeat.com's FREE daily email newsletter.